Concepedia

Publication | Closed Access

Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin.

32

Citations

12

References

2010

Year

Etienne Abdelnour‐Berchtold, Yannick Cerantola, Didier Roulin, Anne Dormond-Meuwly, Nicolas Demartines, Olivier Dormond
PubMed

Abstract

Taken together these results show that rapamycin-induced FOXO1 inactivation reduces the antitumor efficacy of rapamycin.

References

YearCitations

Page 1